Skip to content
  • About
  • Contact
  • Contribute
  • My Book
  • Careers
  • Podcast
  • Transcripts
  • Speaking
KevinMD
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • My Book
    • Careers
    • Podcast
    • Transcripts
    • Speaking
KevinMD
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • My Book
    • Careers
    • Podcast
    • Transcripts
    • Speaking
  • About Kevin Pho, MD, Founder of KevinMD
  • Be heard on social media’s leading physician voice
  • Contact Kevin
  • Custom enhanced author page pricing
  • DMCA Policy
  • Establishing, Managing, and Protecting Your Online Reputation: A Social Media Guide for Physicians and Medical Practices
  • KevinMD influencer opportunities
  • Opinion and commentary by KevinMD
  • Physician burnout speakers to keynote your conference
  • Physician Coaching by KevinMD
  • Physician keynote speaker: Kevin Pho, MD
  • Physician Speaking by KevinMD: a boutique speakers bureau
  • Primary care physician in Nashua, NH | Kevin Pho, MD
  • Privacy Policy
  • Recommended services by KevinMD
  • Terms of Use Agreement
  • Thank you for subscribing to KevinMD
  • Thank you for upgrading to the KevinMD enhanced author page
  • Upgrade to the KevinMD enhanced author page

Are you a medical liberal or a conservative?

Michael Kirsch, MD
Medications
August 9, 2014
Share
Tweet
Share

Our nation is highly polarized today, and often bitterly so.  Democrats rail against the GOP.  Pro-lifers face down pro-choicers.  Fox News disses MSNBC.  Isolationists push back against expansionists.  Traditionalists disdain the politically correct.  Free marketers duel against government advocates.  Carnivores deride the gluten-free crowd.  Martin Bashir trashes Sarah Palin, two proxies in a culture war.

There’s a philosophical divide among physicians also.  Would you prefer a liberal physician or a conservative practitioner?  I’m not referring here to fiscal policy or legalizing recreational marijuana use.  Consider the following hypothetical scenario and the two physicians’ approach from opposite sides of the medical philosophical spectrum. Which physician would you choose?

The patient:  She is a 50-year-old female with chronic fatigue syndrome (CFS).  She is only able to work part time because of her condition.  She has consulted with an internist, an infectious disease specialist and a naturopath, but her fatigue persists.

A new treatment for CFS has just been launched by a reputable herbal supplement company.  Two well-designed studies suggest symptomatic improvement in afflicted patients after 6 months of treatment.  As the product is an herb, there is no formal Food and Drug Administration (FDA) oversight.

Physician #1: “I’m reluctant to recommend this product, despite the optimistic preliminary results from two medical studies.  These studies were funded by the herb company and there may be bias present.  Moreover, it is very typical in medicine for initial results to be favorable, with unforeseen side effects and complications emerging later when after more widespread use of a drug.  I’m concerned that the FDA had no role in validating that the drug is safe and effective for its intended use.  Additionally, there is evidence that the active ingredient in the product disrupts the immune system, which may have serious future consequences that may not become manifest for several years or longer.  While CFS is decreasing your quality of life, your condition has been stable and will never threaten your life.  I recommend holding off until we have an FDA approved medicine for CFS or the herbal supplement has been used long enough that we have a better sense of its safety and efficacy.”

Physician #2: “I recommend that you try this new herbal product.  It is completely natural and showed promising results in two medical studies.  Importantly, no serious side-effects developed in either study.  Of course, we have no long term data on safety, but the vast majority of herbal supplements on the market are safe.  No other treatment thus far has been successful for you, and your condition is adversely affecting your professional and personal lives. The choice is to try something new or to continue suffering as you have been.  Try it for 6 months and then we’ll reassess.”

So, that’s my herb blurb.  This is a common situation in the medical world where medical advice must pass through the prism of risks and benefits.  These analyses are limited when the risks and benefits are unclear or disputed.  Treatment acceptance also depends heavily on the patient’s risk tolerance.  What if the herb referenced above had a 5% risk of cancer?  What if the herb needs to be taken indefinitely? Clearly, when the disease poses a serious medical threat, the patient may be willing to accept greater risk of new or investigational therapies.

So, which of these physicians would you choose for yourself?  Are you a medical liberal or a conservative?

Michael Kirsch is a gastroenterologist who blogs at MD Whistleblower. 

Prev

Learning from the lessons of night float

August 9, 2014 Kevin 1
…
Next

Context is crucial when deciding what to do with abnormal test results

August 9, 2014 Kevin 4
…

Tagged as: Medications and Prescribing

< Previous Post
Learning from the lessons of night float
Next Post >
Context is crucial when deciding what to do with abnormal test results

ADVERTISEMENT

More by Michael Kirsch, MD

  • Are Ozempic patients on a slow-moving runaway train?

    Michael Kirsch, MD
  • AI-driven diagnostics and beyond

    Michael Kirsch, MD
  • The surprising truth behind virtual visits

    Michael Kirsch, MD

More in Medications

  • Is anticoagulation bleeding risk worse in the real world?

    David K. Cundiff, MD
  • Heparin for acute coronary syndrome: a closer look

    David K. Cundiff, MD
  • 5 ways drug ads mislead patients on TV

    M. Bennet Broner, PhD
  • Peptide regulation: 4 lanes every physician must know

    Benjamin González, MD
  • Why physicians need to learn cannabis medicine now

    Janice Makela, MD
  • Medication adherence is a communication problem

    Vimal Patel, RPh
  • Most Popular

  • Past Week

    • DEA fear is reshaping how doctors prescribe

      Ronald L. Lindsay, MD | Physician
    • The double standard at the heart of chronic pain treatment

      Joshua Saylor | Conditions and Diseases
    • Your sinus infection may not be an infection

      Franklyn R. Gergits, DO, MBA | Conditions and Diseases
    • Insurance denial after transplant: approval isn’t access

      Payton Herres | Conditions and Diseases
    • I built clinical decision-support tools at the bedside

      Ahmed Elsonbaty, MD | Health Technology
    • Peptide regulation: 4 lanes every physician must know

      Benjamin González, MD | Medications
  • Past 6 Months

    • Primary care crisis requires new training and skills

      Justin Oldfield, MD | Physician
    • Polycystic ovary syndrome is more than ovarian

      Oluyemisi Famuyiwa, MD | Conditions and Diseases
    • DEA fear is reshaping how doctors prescribe

      Ronald L. Lindsay, MD | Physician
    • Expanding the SOAP framework boosts health outcomes

      Deepak Gupta, MD and Sarwan Kumar, MD | Physician
    • Primary care access is the real problem, not the system

      Payam Zamani, MD | Physician
    • How corporate medicine is eroding truth and patient dignity

      Ronald L. Lindsay, MD | Physician
  • Recent Posts

    • Insurance denial after transplant: approval isn’t access

      Payton Herres | Conditions and Diseases
    • The MCAT requirement persists as a norm, not as a tool

      Aniruth Ananthanarayanan | Medical Education
    • Physician burnout is not the whole diagnosis

      Gus W. Krucke, MD | Physician
    • Prenatal testing for Down syndrome is not a verdict

      Laurel A. Coons, PhD | Conditions and Diseases
    • Why scientific creativity and aging defy citations

      Rao M. Uppu, PhD | Medical Education
    • What does mental health when bedbound actually look like?

      Kristian Keefer | Conditions and Diseases

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 12 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • DEA fear is reshaping how doctors prescribe

      Ronald L. Lindsay, MD | Physician
    • The double standard at the heart of chronic pain treatment

      Joshua Saylor | Conditions and Diseases
    • Your sinus infection may not be an infection

      Franklyn R. Gergits, DO, MBA | Conditions and Diseases
    • Insurance denial after transplant: approval isn’t access

      Payton Herres | Conditions and Diseases
    • I built clinical decision-support tools at the bedside

      Ahmed Elsonbaty, MD | Health Technology
    • Peptide regulation: 4 lanes every physician must know

      Benjamin González, MD | Medications
  • Past 6 Months

    • Primary care crisis requires new training and skills

      Justin Oldfield, MD | Physician
    • Polycystic ovary syndrome is more than ovarian

      Oluyemisi Famuyiwa, MD | Conditions and Diseases
    • DEA fear is reshaping how doctors prescribe

      Ronald L. Lindsay, MD | Physician
    • Expanding the SOAP framework boosts health outcomes

      Deepak Gupta, MD and Sarwan Kumar, MD | Physician
    • Primary care access is the real problem, not the system

      Payam Zamani, MD | Physician
    • How corporate medicine is eroding truth and patient dignity

      Ronald L. Lindsay, MD | Physician
  • Recent Posts

    • Insurance denial after transplant: approval isn’t access

      Payton Herres | Conditions and Diseases
    • The MCAT requirement persists as a norm, not as a tool

      Aniruth Ananthanarayanan | Medical Education
    • Physician burnout is not the whole diagnosis

      Gus W. Krucke, MD | Physician
    • Prenatal testing for Down syndrome is not a verdict

      Laurel A. Coons, PhD | Conditions and Diseases
    • Why scientific creativity and aging defy citations

      Rao M. Uppu, PhD | Medical Education
    • What does mental health when bedbound actually look like?

      Kristian Keefer | Conditions and Diseases

MedPage Today Professional

An Everyday Health Property Medpage Today

Copyright © 2026 KevinMD.com | Powered by Astra WordPress Theme

  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Are you a medical liberal or a conservative?
12 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...